Eversept Partners, LP
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 86% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
111 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 82.7% | $1,504,023,284 |
| Unclassified | 11.4% | $207,359,246 |
| Real Estate | 5.9% | $106,924,282 |
| Financial Services | 0.0% | $510,306 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BKD | Brookdale Senior Living Inc. | +3,193,626 | 3,568,555 | $48,817,832 | |
| GERN | Geron Corp | +1,174,900 | 18,834,883 | $28,063,975 | |
| BBNX | Beta Bionics, Inc. | +736,576 | 1,414,838 | $14,176,676 | |
| CYH | Community Health Systems Inc | +733,479 | 8,677,281 | $25,511,206 | |
| CTMX | CytomX Therapeutics, Inc. | +681,424 | 3,188,514 | $14,986,015 | |
| ARDX | Ardelyx, Inc. | +514,317 | 2,229,446 | $13,354,381 | |
| CLDX | Celldex Therapeutics, Inc. | +353,291 | 1,788,016 | $56,715,867 | |
| ALEC | Alector, Inc. | +344,943 | 1,351,106 | $2,904,877 | |
| ABVX | Abivax S.A. | +276,589 | 934,423 | $104,048,001 | |
| SVRA | Savara Inc | +214,069 | 384,264 | $2,098,081 | |
| LQDA | Liquidia Corp | +167,949 | 677,392 | $25,564,774 | |
| ARQT | Arcutis Biotherapeutics, Inc. | +141,946 | 576,580 | $13,584,224 | |
| IVVD | Invivyd, Inc. | +136,219 | 2,276,349 | $2,959,253 | |
| BMRN | Biomarin Pharmaceutical Inc | +114,020 | 207,768 | $11,736,814 | |
| IONS | Ionis Pharmaceuticals Inc | +93,882 | 632,100 | $47,464,389 | |
| EHC | Encompass Health Corp | +87,178 | 194,104 | $18,775,679 | |
| PODD | Insulet Corp | +68,838 | 143,546 | $30,121,692 | |
| SPY | Spdr S&P 500 ETF Trust | +62,100 | 107,000 | $69,586,380 | |
| ENGN | enGene Therapeutics Inc. | +54,708 | 510,543 | $3,476,797 | |
| NTRA | Natera, Inc. | +50,220 | 384,713 | $76,938,752 | |
| PLRX | Pliant Therapeutics, Inc. | +49,402 | 891,425 | $1,123,195 | |
| BCRX | Biocryst Pharmaceuticals Inc | +46,925 | 3,039,820 | $28,939,086 | |
| WHWK | Whitehawk Therapeutics, Inc. | +46,541 | 306,800 | $1,058,460 | |
| SSII | SS Innovations International, Inc. | +34,799 | 110,157 | $550,785 | |
| PNTG | Pennant Group, Inc. | +18,218 | 312,178 | $9,515,185 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | −2,115,170 | 1,735,963 | $4,756,538 | |
| VRDN | Viridian Therapeutics, Inc.\DE | −1,068,966 | 713,269 | $13,951,541 | |
| VERA | Vera Therapeutics, Inc. | −899,018 | 2,173,286 | $87,431,295 | |
| GSK | GSK plc | −894,546 | 1,785,175 | $98,523,808 | |
| BRKR | Bruker Corp | −666,776 | 117,013 | $4,226,509 | |
| TVTX | Travere Therapeutics, Inc. | −632,358 | 542,610 | $16,120,943 | |
| SNDX | Syndax Pharmaceuticals Inc | −428,786 | 2,885,622 | $67,408,129 | |
| PALI | Palisade Bio, Inc. | −404,049 | 4,987,499 | $8,728,123 | |
| BVS | Bioventus Inc. | −312,147 | 159,110 | $1,452,674 | |
| PCVX | Vaxcyte, Inc. | −273,529 | 924,193 | $53,704,855 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −254,607 | 62,575 | $1,310,946 | |
| TECH | BIO-TECHNE Corp | −251,509 | 125,896 | $6,579,324 | |
| TYRA | Tyra Biosciences, Inc. | −251,509 | 27,055 | $1,036,206 | |
| RLAY | Relay Therapeutics, Inc. | −218,432 | 270,705 | $2,693,514 | |
| CNC | Centene Corp | −212,440 | 111,652 | $3,655,486 | |
| AVTR | Avantor, Inc. | −202,357 | 2,974,287 | $23,318,410 | |
| NAMS | NewAmsterdam Pharma Co N.V. | −135,063 | 285,764 | $9,147,305 | |
| HQY | Healthequity, Inc. | −134,125 | 51,614 | $4,313,381 | |
| STRO | Sutro Biopharma, Inc. | −120,410 | 73,161 | $1,822,440 | |
| ASMB | Assembly Biosciences, Inc. | −118,787 | 40,889 | $1,134,669 | |
| SPRY | ARS Pharmaceuticals, Inc. | −115,358 | 136,235 | $1,093,967 | |
| MRNA | Moderna, Inc. | −108,115 | 159,708 | $8,113,166 | |
| XENE | Xenon Pharmaceuticals Inc. | −101,806 | 129,574 | $7,534,728 | |
| AVR | Anteris Technologies Global Corp. | −98,813 | 401,187 | $2,226,587 | |
| ANAB | Anaptysbio, Inc | −93,838 | 27,089 | $1,502,354 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | 1,021,630 | $40,906,065 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | 90,000 | $40,188,600 | |
| WELL | Welltower Inc. | 180,953 | $35,776,217 | |
| DOC | Healthpeak Properties, Inc. | 1,981,070 | $32,548,980 | |
| OHI | Omega Healthcare Investors Inc | 585,680 | $25,664,497 | |
| INSM | INSMED Inc | 94,000 | $15,370,880 | |
| RGEN | Repligen Corp | 120,785 | $14,230,888 | |
| LTC | Ltc Properties Inc | 321,046 | $11,930,069 | |
| CHE | Chemed Corp | 31,057 | $11,731,471 | |
| VKTX | Viking Therapeutics, Inc. | 239,110 | $7,780,639 | |
| AGIO | Agios Pharmaceuticals, Inc. | 200,000 | $6,766,000 | |
| THC | Tenet Healthcare Corp | 29,512 | $5,569,209 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 10,000 | $5,234,700 | |
| PRAX | Praxis Precision Medicines, Inc. | 14,800 | $4,768,412 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 183,902 | $3,942,858 | |
| CMPS | COMPASS Pathways plc | 677,924 | $3,748,919 | |
| GRCE | Grace Therapeutics, Inc. | 756,600 | $3,503,058 | |
| UHS | Universal Health Services Inc | 18,200 | $3,257,254 | |
| DFTX | Definium Therapeutics, Inc. | 160,723 | $3,037,664 | |
| EQ | Equillium, Inc. | 1,498,993 | $2,997,986 | |
| ENSG | Ensign Group, Inc | 14,761 | $2,974,341 | |
| REPL | Replimune Group, Inc. | 386,861 | $2,959,486 | |
| PMVP | PMV Pharmaceuticals, Inc. | 2,348,360 | $2,911,966 | |
| ANRO | Alto Neuroscience, Inc. | 125,168 | $2,813,776 | |
| LBRX | Lb Pharmaceuticals Inc | 100,198 | $2,470,882 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| DHR | Danaher Corp /De/ | 186,262 | $42,639,097 | |
| EXAS | EXACT SCIENCES CORP | 241,678 | $24,544,817 | |
| TEVA | Teva Pharmaceutical Industries Ltd | 660,177 | $20,604,124 | |
| BIIB | Biogen Inc. | 77,944 | $13,717,364 | |
| SEM | Select Medical Holdings Corp | 906,100 | $13,455,585 | |
| CGON | CG Oncology, Inc. | 308,466 | $12,807,508 | |
| BMY | Bristol Myers Squibb Co | 235,293 | $12,691,704 | |
| ELV | Elevance Health, Inc. | 30,195 | $10,584,857 | |
| MNKD | Mannkind Corp | 1,852,563 | $10,504,032 | |
| ASND | Ascendis Pharma A/S | 48,241 | $10,286,910 | |
| ILMN | Illumina, Inc. | 76,721 | $10,062,726 | |
| EWTX | Edgewise Therapeutics, Inc. | 337,340 | $8,371,092 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 358,168 | $8,359,641 | |
| HUM | Humana Inc | 32,462 | $8,314,492 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 10,097 | $7,793,571 | |
| CVS | CVS HEALTH Corp | 63,696 | $5,054,914 | |
| ACAD | Acadia Pharmaceuticals Inc | 176,594 | $4,716,825 | |
| PTGX | Protagonist Therapeutics, Inc | 52,961 | $4,625,613 | |
| ZBIO | Zenas BioPharma, Inc. | 121,016 | $4,394,090 | |
| NHC | National Healthcare Corp | 28,577 | $3,917,620 | |
| FTRE | Fortrea Holdings Inc. | 224,139 | $3,866,397 | |
| MRVI | Maravai Lifesciences Holdings, Inc. | 718,582 | $2,335,391 | |
| EOLS | Evolus, Inc. | 344,104 | $2,288,291 | |
| RAPP | Rapport Therapeutics, Inc. | 59,233 | $1,797,129 | |
| BHVN | Biohaven Ltd. | 145,431 | $1,641,915 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 264,271 | $156,707,417 | 8.62% | |
| QQQ |
Invesco Qqq Trust, Series 1
PUT
|
Added | 238,700 | $137,772,866 | 7.57% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 934,423 | $104,048,001 | 5.72% | |
| GSK |
GSK plc
Healthcare
|
Reduced | 1,785,175 | $98,523,808 | 5.42% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 2,173,286 | $87,431,295 | 4.81% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 384,713 | $76,938,752 | 4.23% | |
| SPY |
Spdr S&P 500 ETF Trust
PUT
|
Added | 107,000 | $69,586,380 | 3.83% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 2,885,622 | $67,408,129 | 3.71% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Added | 1,788,016 | $56,715,867 | 3.12% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 924,193 | $53,704,855 | 2.95% | |
| BKD |
Brookdale Senior Living Inc.
Healthcare
|
Added | 3,568,555 | $48,817,832 | 2.68% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 632,100 | $47,464,389 | 2.61% | |
| QGEN |
Qiagen N.V.
CALL
+ SHARES
Healthcare
|
NEW | 1,021,630 | $40,906,065 | 2.25% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
CALL
Healthcare
|
NEW | 90,000 | $40,188,600 | 2.21% | |
| HCA |
HCA Healthcare, Inc.
Healthcare
|
Reduced | 79,229 | $37,494,331 | 2.06% | |
| WELL |
Welltower Inc.
Real Estate
|
NEW | 180,953 | $35,776,217 | 1.97% | |
| DOC |
Healthpeak Properties, Inc.
Real Estate
|
NEW | 1,981,070 | $32,548,980 | 1.79% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 143,546 | $30,121,692 | 1.66% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Added | 3,039,820 | $28,939,086 | 1.59% | |
| GERN |
Geron Corp
Healthcare
|
Added | 18,834,883 | $28,063,975 | 1.54% | |
| OHI |
Omega Healthcare Investors Inc
Real Estate
|
NEW | 585,680 | $25,664,497 | 1.41% | |
| LQDA |
Liquidia Corp
Healthcare
|
Added | 677,392 | $25,564,774 | 1.41% | |
| CYH |
Community Health Systems Inc
Healthcare
|
Reduced | 8,677,281 | $25,511,206 | 1.40% | |
| AVTR |
Avantor, Inc.
Healthcare
|
Reduced | 2,974,287 | $23,318,410 | 1.28% | |
| EHC |
Encompass Health Corp
Healthcare
|
Added | 194,104 | $18,775,679 | 1.03% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 19,000 | $17,475,630 | 0.96% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 542,610 | $16,120,943 | 0.89% | |
| INSM |
INSMED Inc
CALL
Healthcare
|
NEW | 94,000 | $15,370,880 | 0.85% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 3,188,514 | $14,986,015 | 0.82% | |
| RGEN |
Repligen Corp
Healthcare
|
NEW | 120,785 | $14,230,888 | 0.78% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 1,414,838 | $14,176,676 | 0.78% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Reduced | 713,269 | $13,951,541 | 0.77% | |
| ARQT |
Arcutis Biotherapeutics, Inc.
Healthcare
|
Added | 576,580 | $13,584,224 | 0.75% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Added | 2,229,446 | $13,354,381 | 0.73% | |
| LTC |
Ltc Properties Inc
Real Estate
|
NEW | 321,046 | $11,930,069 | 0.66% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Added | 207,768 | $11,736,814 | 0.65% | |
| CHE |
Chemed Corp
Healthcare
|
NEW | 31,057 | $11,731,471 | 0.65% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Reduced | 406,960 | $11,496,620 | 0.63% | |
| UNH |
Unitedhealth Group Inc
CALL
Healthcare
|
Reduced | 40,000 | $10,823,600 | 0.60% | |
| PNTG |
Pennant Group, Inc.
Healthcare
|
Added | 312,178 | $9,515,185 | 0.52% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Reduced | 285,764 | $9,147,305 | 0.50% | |
| PALI |
Palisade Bio, Inc.
Healthcare
|
Reduced | 4,987,499 | $8,728,123 | 0.48% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Reduced | 159,708 | $8,113,166 | 0.45% | |
| VKTX |
Viking Therapeutics, Inc.
Healthcare
|
NEW | 239,110 | $7,780,639 | 0.43% | |
| ICLR |
Icon PLC
Healthcare
|
Reduced | 68,688 | $7,601,014 | 0.42% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 129,574 | $7,534,728 | 0.41% | |
| RVTY |
Revvity, Inc.
Healthcare
|
Reduced | 84,854 | $7,434,058 | 0.41% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 200,000 | $6,766,000 | 0.37% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Added | 138,036 | $6,653,335 | 0.37% | |
| TECH |
BIO-TECHNE Corp
Healthcare
|
Reduced | 125,896 | $6,579,324 | 0.36% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.